Published in World J Surg on June 08, 1995
Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg (1996) 5.42
Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg (2007) 3.73
Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg (1996) 2.54
Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg (1997) 1.36
Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period. Ann Surg (2005) 1.32
Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg (2002) 0.98
Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma. J Cancer Res Clin Oncol (2009) 0.96
Surgery and chemotherapy for intrahepatic cholangiocarcinoma. World J Hepatol (2010) 0.94
Long-term outcome of photodynamic therapy with systemic chemotherapy compared to photodynamic therapy alone in patients with advanced hilar cholangiocarcinoma. Gut Liver (2014) 0.92
Unexpected response to systemic chemotherapy in case of primarily nonresectable advanced disseminated intrahepatic cholangiocarcinoma. World J Surg Oncol (2007) 0.88
Current status of intrahepatic cholangiocarcinoma. World J Gastroenterol (2008) 0.87
Cholangiocarcinoma: has there been any progress? Can J Gastroenterol (2010) 0.82
Accomplishments in 2007 in the management of hepatobiliary cancers. Gastrointest Cancer Res (2008) 0.81
Liver transplantation for cholangiocarcinoma: Current status and new insights. World J Hepatol (2015) 0.81
Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver. World J Gastroenterol (2005) 0.81
Radiofrequency ablation of recurrent cholangiocarcinoma after orthotopic liver transplantation -- a case report. World J Gastroenterol (2005) 0.81
Colonic metastasis of Klatskin tumor: case report and discussion of the current literature. World J Gastroenterol (2006) 0.80
Liver transplantation is not indicated for cholangiocarcinoma. HPB (Oxford) (2003) 0.77
R0 liver resections for primary malignant liver tumors in the noncirrhotic liver: a diagnosis-related analysis. Dig Dis Sci (2008) 0.75
Decision Making: Intra-arterial Therapies for Cholangiocarcinoma-TACE and TARE. Semin Intervent Radiol (2017) 0.75
Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg (1991) 3.12
Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg (1996) 2.54
Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study. Lancet (2001) 2.39
Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol (1997) 2.16
Impaired erythropoiesis after haemorrhagic shock in mice is associated with erythroid progenitor apoptosis in vivo. Acta Anaesthesiol Scand (2008) 2.04
ESPEN Guidelines on Parenteral Nutrition: surgery. Clin Nutr (2009) 2.03
[Transplantation of a donor liver to 2 recipients (splitting transplantation)--a new method in the further development of segmental liver transplantation]. Langenbecks Arch Chir (1988) 2.02
Benign liver tumors: differential diagnosis and indications for surgery. World J Surg (1997) 1.83
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
Hepatic transplantation in Europe. First Report of the European Liver Transplant Registry. Lancet (1987) 1.68
Transfer of the HIV-1 cyclophilin-binding site to simian immunodeficiency virus from Macaca mulatta can confer both cyclosporin sensitivity and cyclosporin dependence. Proc Natl Acad Sci U S A (1997) 1.68
Technique and preliminary results of extracorporeal liver surgery (bench procedure) and of surgery on the in situ perfused liver. Br J Surg (1990) 1.60
Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease. J Virol (1997) 1.55
Cystic enlargement of extrahepatic bile ducts. Surgery (1993) 1.53
Radical resection and liver grafting as the two main components of surgical strategy in the treatment of proximal bile duct cancer. World J Surg (1988) 1.51
What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer (1997) 1.43
Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression. Clin Chem (1994) 1.43
ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr (1997) 1.40
Can the prognosis of liver transplantation for hepatocellular carcinoma be predicted? Hepatology (1997) 1.40
Adenine nucleotide metabolism and its relation to organ viability in human liver transplantation. Transplantation (1988) 1.39
Development of liver size and perfusion after reduced-size liver transplantation in children. Pediatr Transplant (2001) 1.39
Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol (1999) 1.38
[Inter-observer reliability in the classification of thoraco-lumbar spinal injuries]. Orthopade (1999) 1.37
Hepatocellular carcinoma. Br J Surg (1998) 1.35
Evaluation of the mobility of adjacent segments after posterior thoracolumbar fixation: a biomechanical study. Eur Spine J (2001) 1.34
Active-site residues of cyclophilin A are crucial for its incorporation into human immunodeficiency virus type 1 virions. J Virol (1997) 1.25
Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology (1997) 1.24
Indications for liver transplantation in hepatobiliary malignancy. Hepatology (1994) 1.23
Liver transplantation. Transplant Proc (1987) 1.23
Lignocaine metabolite formation as a measure of pre-transplant liver function. Lancet (1989) 1.23
Results of hepatic resection and transplantation for fibrolamellar carcinoma. Surg Gynecol Obstet (1992) 1.17
Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit? J Hepatol (1998) 1.17
Nutritional consequences of total gastrectomy: the relationship between mode of reconstruction, postprandial symptoms, and body composition. Surgery (1990) 1.16
Resection of synchronous liver metastases from colorectal cancer. World J Surg (1991) 1.15
Donor-type microchimerism associated with graft rejection eight years after liver transplantation. N Engl J Med (1994) 1.13
Emptying of the gastric substitute after total gastrectomy. Jejunal interposition versus Roux-y esophagojejunostomy. Ann Surg (1989) 1.12
Liver transplantation for metastatic neuroendocrine tumors. Ann Surg (1997) 1.09
Update of current immunosuppressive drugs used in clinical organ transplantation. Transpl Int (1998) 1.07
Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma. Br J Surg (2000) 1.06
Monoethylglycinexylidide formation kinetics: a novel approach to assessment of liver function. J Clin Chem Clin Biochem (1987) 1.04
Persistence of donor lymphocytes in liver allograft recipients. Transplantation (1993) 1.02
Association of elevated FK 506 plasma levels with nephrotoxicity in liver-grafted patients. Transplant Proc (1991) 1.00
Results of biliary reconstruction after liver transplantation. Transplant Proc (1984) 1.00
Squamous cell carcinoma of the liver originating from a solitary non-parasitic cyst case report and review of the literature. HPB Surg (1996) 0.99
Appraisal of transplantation for malignant tumours of the liver with special reference to early stage hepatocellular carcinoma. Eur J Surg Oncol (1998) 0.99
Hepatic retransplantation: the Hannover experience of two decades. Transplant Proc (1993) 0.99
Significance of arterial ketone body ratio measurement in human liver transplantation. Transplantation (1990) 0.97
Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol (1991) 0.97
Structural analysis of drug-DNA adducts by tandem mass spectrometry. Analyst (2000) 0.96
Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites. Transplant Proc (1998) 0.96
Neoadjuvant photodynamic therapy before curative resection of proximal bile duct carcinoma. J Hepatol (2000) 0.95
Complex fractures of the proximal humerus in the elderly--outcome and complications after locking plate fixation. Musculoskelet Surg (2012) 0.95
Situs inversus of donor or recipient in liver transplantation. Transpl Int (1998) 0.94
Vascular problems in liver transplantation. Transplant Proc (1987) 0.93
Long-term side effects of cyclosporine-based immunosuppression in patients after liver transplantation. Transplant Proc (1994) 0.93
[Ex situ operation on the liver. A new possibility in liver surgery]. Langenbecks Arch Chir (1988) 0.93
Liver grafting for malignant liver tumors. Transplant Proc (1989) 0.92
Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation. Hepatology (1996) 0.92
Role of liver transplantation in the treatment of unresectable liver cancer. World J Surg (1996) 0.91
Extramedullary erythropoiesis in human liver grafts. Hepatology (1995) 0.91
Rescue hepatectomy for initial graft non-function after liver transplantation. Transplantation (1999) 0.90
A study of kynurenine fragmentation using electrospray tandem mass spectrometry. J Am Soc Mass Spectrom (2001) 0.90
Liver metastases of breast cancer: results of liver resection. Anticancer Res (1998) 0.89
Prostaglandin E plus famciclovir--a new concept for the treatment of severe hepatitis B after liver transplantation. Transplantation (1994) 0.89
Anaemia associated with FK 506 immunosuppression. Lancet (1993) 0.89
Pregnancy in women with observed focal nodular hyperplasia of the liver. Lancet (1998) 0.89
Treatment of inherited metabolic disorders by liver transplantation. J Inherit Metab Dis (1991) 0.88
An ex vivo model to study the intestinal biotransformation of immunosuppressives. Transplant Proc (2000) 0.88
Successful pregnancy in a patient after liver transplantation maintained on FK 506. Transplantation (1993) 0.88
The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases. Eur J Endocrinol (2004) 0.88
Liver transplantation for hepatocellular carcinoma: clinical results and future aspects. Cancer Chemother Pharmacol (1992) 0.88
Mast cells distribution in human liver disease and experimental rat liver fibrosis. Indications for mast cell participation in development of liver fibrosis. J Hepatol (1997) 0.87
Is a fatty liver dangerous for transplantation? Transplant Proc (1999) 0.87
Immunonutrition in patients after multiple trauma. Br J Nutr (2002) 0.87
Graves' disease is associated with an altered CXCR3 and CCR5 expression in thyroid-derived compared to peripheral blood lymphocytes. Clin Exp Immunol (2002) 0.86
Bile duct injury as a part of diagnostic criteria for liver allograft rejection. Hum Pathol (1989) 0.86
Pantoprazole does not affect cyclosporin A blood concentration in kidney-transplant patients. Eur J Clin Pharmacol (2000) 0.86